Latest filing published 02 Nov 2022 for Alimera Sciences INC, €1,658.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John Philip Jones: trading record in brief
This profile gathers the share dealings of John Philip Jones in Alimera Sciences Inc, where the filings describe the role as finance chief. We count 32 filings; the first trade dates from 22 January 2019 and the latest from 31 October 2022.
Every open-market trade on record is a purchase: 3 purchases worth €29k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 29 share grants.
In size, the median ticket on the buying side is €8,396.
Most recently, on 2 November 2022, the filings show a share grant worth €1,658 in Alimera Sciences Inc. The most recent open-market purchase was published on 4 November 2021, 1,831 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to John Philip Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 372 shares@ US$4.4377.1% of flowCommon StockSEC:0001762007-22-000003:0
- 426 shares@ US$3.7576.5% of flowCommon StockSEC:0001474506-22-000038:0
- 8,750 shares0Common StockSEC:0001474506-22-000010:0
- 5,000 shares@ US$4.079875.6% of flowCommon StockSEC:0001474506-21-000158:0Canonical exit: 1 Feb 2022 (T+90)
- 399 shares@ US$3.7575.5% of flowCommon StockSEC:0001474506-21-000154:0
- 421 shares@ US$3.56155.3% of flowCommon StockSEC:0001474506-21-000083:0
- 1,164 shares@ US$7.6411.3% of flowCommon StockSEC:0001474506-21-000056:0
- 5,625 shares0Common StockSEC:0001474506-21-000030:0
- 421 shares@ US$3.56153.5% of flowCommon StockSEC:0001474506-20-000293:0
- 167 shares@ US$3.611.0% of flowCommon StockSEC:0001267602-20-000075:0
- 3,958 shares0Common StockSEC:0001267602-20-000053:0
- 938 shares@ US$7.0510.9% of flowCommon StockSEC:0001267602-20-000035:0
- 938 shares@ US$6.159.5% of flowCommon StockSEC:0001267602-20-000035:1
- 78 shares@ US$7.580.9% of flowCommon StockSEC:0001267602-20-000008:0
- 72 shares@ US$8.240.9% of flowCommon StockSEC:0001267602-19-000214:0
- 1,000 shares@ US$9.2914.3% of flowCommon StockSEC:0001267602-19-000206:0Canonical exit: 9 Mar 2020 (T+90)
- 105 shares@ US$5.660.9% of flowCommon StockSEC:0001267602-19-000201:0
- 125 shares@ US$4.750.9% of flowCommon StockSEC:0001267602-19-000190:0
- 2,104 shares@ US$0.28340.9% of flowCommon StockSEC:0001267602-19-000164:0
- 2,500 shares@ US$0.24090.9% of flowCommon StockSEC:0001267602-19-000164:1
- 10,000 shares@ US$0.30084.6% of flowCommon StockSEC:0001267602-19-000164:2
- 1,490 shares@ US$0.400.9% of flowCommon StockSEC:0001267602-19-000149:0
- 1,046 shares@ US$0.570.9% of flowCommon StockSEC:0001267602-19-000136:0
- 1,454 shares@ US$0.410.9% of flowCommon StockSEC:0001267602-19-000122:0
- 1,633 shares@ US$0.82452.0% of flowCommon StockSEC:0001267602-19-000070:0
25 of 31 declarations